Bodycote Plc - November Trading Update
Bodycote plc - November Trading Update
Improved momentum in mixed markets
Bodycote, the world's leading provider of specialist thermal processing services, issues a trading update covering the four-month period from 1 July to ("the period").
Key points
Trading Summary
Core revenue was 2.2% higher organically during the four months, resulting in a reduced year-to-date decline of 1.4%. Including the impact of Non-Core plant closures as we continue to progress our Optimise programme, Group organic revenue was broadly stable in the period (+0.3%) and is 2.7% lower year-to-date at £613m.
End markets remain mixed, with strong growth achieved in Aerospace & Defence which accelerated sequentially in the period. In Automotive we delivered low single-digit growth year-on-year in the period, reflecting stronger light vehicle production trends in Q3, although these are expected to soften again in Q4. Industrial Markets remain challenging, particularly in , albeit comparators have become easier resulting in a more modest year-on-year decline in the period compared with H1. In Oil & Gas, low levels of upstream investment and drilling in the has resulted in customer-driven delays to the ramp-up of some of our recent contract wins.
Specialist Technologies
Momentum improved through the period, with stronger year-on-year growth notably in September and October. Organic revenue in the period was 1.8% below prior year and is now 5.4% lower year-to-date. Growth in Aerospace & Defence accelerated materially, led by a significant ramp-up in LEAP engine related work in Surface Technology. Oil & Gas remained a significant headwind, driven by delays in the ramp-up of some of our recent contract wins in the . Industrial Markets also remained weak, particularly in . In HIP Product Fabrication (HIP PF), we continue to execute on H1 order wins in Defence, with a higher-than-normal level of deliveries anticipated in Q4. We expect an improvement in growth in Specialist Technologies for the remainder of the year, supported by a further acceleration in Aerospace growth alongside higher deliveries in HIP PF, with a degree of dependence on the timing of these deliveries around year-end.
Precision Heat Treatment
Organic revenue in the period grew 4.1% and is now marginally positive year-to-date at 0.6%. This reflected a slight improvement in sequential performance combined with easing comparators versus a weak prior year period. By end market, year-on-year growth was led by Industrial Gas Turbines and Aerospace & Defence, alongside modest growth in Automotive helped by stronger performance in and continued growth in . For the full year, we expect Aerospace & Defence and Industrial Gas Turbines growth to continue, while Industrial and Automotive markets are likely to remain challenging.
Optimise, Perform & Grow
We continue to make good progress across our Optimise, Perform and Grow initiatives. Activity on the Optimise programme accelerated in the period, including an increased pace of revenue transfer to our Core Precision Heat Treatment sites, benefitting utilisation levels at these plants. The planned disposal of 10 Automotive and Industrial sites in (announced with our 2025 Half Year Results) is on track and nearing completion. We also expect to have fully exited more than one third of the 20 remaining Non-Core sites by year end. We remain on track to deliver a £4-5m full year Optimise benefit to Core operating profit and are confident of reaching at least £15m run-rate benefits by mid-2027. Non-Core revenue and profit will continue to decline as we execute on further closures.
We are advancing with the deployment of the HEAT framework to improve operational performance. Significant progress has been made on the roll out of important lean productivity tools, with around 90% of Core sites having these in place by year-end. As we move into 2026 and beyond, we expect to see gradually increasing benefits from improved operational execution.
As part of our focus on driving enhanced future growth, we are making a number of organic investments in our target areas. We are progressing with the major upgrade and expansion of two US Precision Heat Treatment sites focused on Aerospace and IGT. In HIP, we are investing in additional capacity in both and to support continued growth in Aerospace activity. Initial work is also progressing on the new greenfield site for S
Outlook
We continue to expect to deliver stronger profit performance in H2 versus H1, driven by further growth in Aerospace & Defence, improved Specialist Technologies trading and increasing benefits from the Optimise programme. As a result, operating profit in H2 is expected to be ahead of H1 and broadly similar to the level seen in H2 2024.2Our focus remains on execution as well as delivering on our Optimise, Perform and Grow initiatives which will create a higher quality, more resilient and faster growing Bodycote.
1Core business excludes Non-Core plants to be exited as part of the Optimise programme
2H2 2024 adjusted operating profit: £62.2m
For further information, please contact:
Bodycote plc
, Chief Executive Officer
, Chief Financial Officer
, Investor Relations and FP&A
Tel: +44 1625 505 300
FTI Consulting
Tel: +44 203 727 1340
Disclosures:
This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.
-- Core1: organic revenue growth of 2.2% year-on-year in the period, with
improved momentum in almost all end markets; year-to-date (YTD) now 1.4%
lower than prior year (H1: -3.6%)
-- Group: organic revenue growth of 0.3% year-on-year in the period, after
headwinds from Non-Core plant closures; YTD organic revenue now 2.7%
lower than prior year (H1: -4.6%)
-- Further good progress on plant closures and revenue transfers as part of
the Optimise programme; sale of 10 French Automotive and Industrial
sites on track and nearing completion
-- Strong growth in Aerospace & Defence in the period with improving
momentum; Automotive and Industrial remained challenging with improved
year-on-year trends due to easier comparators
-- Continue to expect increased profit in H2 vs H1, driven by improved
Specialist Technologies trading and Optimise benefits; H2 operating
profit expected to be broadly in line with H2 20242
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE